PRC2 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

72 results for “PRC2”

Trials

View all 45 →

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

25 participants · First posted May 4, 2021

Sirolimus Treatment for Refractory PRCA

64 participants · First posted Dec 7, 2017

EA for PAAS: A pRCT

1,000 participants · First posted Jun 8, 2021

Drugs

View all 11 →

PRC200-SS

DC-PRC2in-01

ARC2-001

Organizations

Prcl Research Inc.

Canada

PRO2 MEDGAS, LLC

United States

PRC TICINUM LAB SRL

Italy

News

View all 13 →

FDA Safety Concerns Force Fulcrum Therapeutics to Halt Sickle Cell Drug Development

ORIC Pharmaceuticals Presents Promising Data on Cancer Drug Candidates at AACR Meeting

ORIC Pharmaceuticals Completes Dose Exploration for ORIC-944 in Prostate Cancer, Shows Promising Efficacy Signals

Page 1 of 8